SHARPS TECHNOLOGY INC. - COMMON STOCK

Sharps Technology, Inc. Closes $3.5 Million Bridge Financing

24 Sep 2024 11:58:06 By Nasdaq GlobeNewswire

Sharps Technology, Inc. Announces $3.5 Million Bridge Financing

23 Sep 2024 05:00:00 By Nasdaq GlobeNewswire

Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders’ Meeting

12 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Sharps Technology Enters Into a Five-Year Sales Agreement with Strategic U.S. Medical Products Company Creating +$5O Million in New Revenue for EU Facility

25 Jul 2024 07:30:00 By Nasdaq GlobeNewswire

Sharps Technology CEO Urges Shareholders to Vote in Support of the Three Proposals by the July 12 Voting Deadline

09 Jul 2024 07:30:00 By Nasdaq GlobeNewswire

Sharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 Delivery

03 Jul 2024 12:05:00 By Nasdaq GlobeNewswire

Sharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024

03 Jul 2024 09:55:32 By Nasdaq GlobeNewswire

Sharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in Colombia

17 Jun 2024 07:30:00 By Nasdaq GlobeNewswire

Join Sharps Technology’s Exclusive Live Investor Webinar and Q&A Session on June 18

14 Jun 2024 12:40:00 By Nasdaq GlobeNewswire

Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility

13 Jun 2024 07:30:00 By Nasdaq GlobeNewswire

Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit

05 Jun 2024 07:30:00 By Nasdaq GlobeNewswire

Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.

31 May 2024 07:30:00 By Nasdaq GlobeNewswire

Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.

30 May 2024 07:30:00 By Nasdaq GlobeNewswire

Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes

28 May 2024 12:00:00 By Nasdaq GlobeNewswire

Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems

07 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia

21 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems

16 Feb 2024 13:42:54 By Nasdaq GlobeNewswire

Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems

18 Jan 2024 08:00:47 By Nasdaq GlobeNewswire

Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement

29 Sep 2023 08:54:45 By Nasdaq GlobeNewswire

Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals

28 Sep 2023 09:52:52 By Nasdaq GlobeNewswire